Editor-in-Chief
Hatice Kübra Elçioğlu
Vice Editors
Levent Kabasakal
Esra Tatar
Online ISSN
2630-6344
Publisher
Marmara University
Frequency
Bimonthly (Six issues / year)
Abbreviation
J.Res.Pharm.
Former Name
Marmara Pharmaceutical Journal
Journal of Research in Pharmacy
2024 , Vol 28 , Issue 1
Antiviral Properties of 5‑Sulfamoyl‑1H‑Indole-Linked Spirothiazolidinone Derivatives: A Study on Human Parainfluenza Virus-2
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, Beyazit 34116, Fatih, Istanbul, Türkiye2Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Istanbul University, Beyazit 34116, Fatih, Istanbul, Türkiye
3Department of Pharmacology, Faculty of Pharmacy, Istinye University, Istanbul, Türkiye DOI : 10.29228/jrp.689 Human parainfluenza viruses (HPIVs) are responsible for a wide range of respiratory infections in humans, particularly in children, the elderly, and immunocompromised individuals. This paper presents a study regarding the antiviral activity of a series of 3-phenyl-5-sulfamoyl-N-(7/8/9-(non)substituted-3-oxo-1-thia-4- azaspiro[4.4]non/[4.5]dec-4-yl)-1H-indole-2-carboxamide derivatives against HPIV-2. Our findings suggest the compounds displayed low potency against HPIV-2. Compounds 4 and 8 exhibited the most potent antiviral effects with inhibition of 95.46 and 90.90 % at 10 mg/mL, respectively. Molecular modeling studies were conducted on hemagglutinin-neuraminidase, a crucial druggable target for HPIV, to predict the binding modes of the compounds. Keywords : parainfluenza virus; HPIV-2; indole; thiazolidinone; hemagglutinin-neuraminidase; molecular docking